Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | Q9HBH1 | 7/20 | 0.51 | |
| ▸ | CNR2 | P34972 | 3/20 | 0.34 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15736879 | 0.80 | PDF (0.37) | PDFTUBB1 | |
| SCHEMBL1219001 | 0.80 | PDF (0.37) | ||
| SCHEMBL27145161 | 0.77 | CNR2 (0.36) | PDFCNR2 | |
| SCHEMBL21543027 | 0.77 | CNR2 (0.36) | PDFCNR2 | |
| SCHEMBL2784044 | 0.77 | CNR2 (0.36) | PDFCNR2 | |
| SCHEMBL883447 | 0.77 | CA2 (0.43) | PDFCNR2 | |
| SCHEMBL8357912 | 0.77 | CA2 (0.43) | PDFCNR2 | |
| SCHEMBL3216755 | 0.76 | CA1 (0.46) | ||
| SCHEMBL12866689 | 0.76 | CA1 (0.46) | ||
| SCHEMBL7409342 | 0.74 | PDF (0.41) |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130072467-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED | 2013-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130072467-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND | ESRRA, ESRRB, ESR2 | PDF 2488/4885CNR2 1542/4885TUBB1 1936/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.